tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Compare Paradigm Biopharmaceuticals (PAR) vs. Competitors

Compare
39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.33
AU$147.84M
-6.94
-22.47%
Imugene
AU$0.34
AU$109.72M
-1.09
-76.94%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$87.00M
-5.26
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Pharmaust Limited
AU$0.08
AU$68.01M
-2.46
-49.38%
0 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.41
AU$189.42M
-7.27
40.86%
Arovella Therapeutics Limited
AU$0.08
AU$108.11M
-13.24
-48.57%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.35
-0.07
-15.85%
AU:IMU
Imugene
0.35
-1.12
-76.40%
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-44.44%
AU:NUZ
Pharmaust Limited
0.08
-0.08
-47.77%
AU:RCE
Recce Pharmaceuticals Ltd.
0.66
0.19
40.86%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-52.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts